Ahlin G[au] - Search Results

Year	Number of Results
1971	1
1977	1
1993	1
1998	1
2007	2
2008	1
2009	1
2010	2
2011	3
2012	1
2015	1
2023	0

1

Ahlin G. Ahlin G. Int J Group Psychother. 2015 Oct;65(4):526-33. doi: 10.1521/ijgp.2015.65.4.526. Int J Group Psychother. 2015. PMID: 26401795 Review.

2

[Puerperal psychoses].

Ahlin G, Björk G, Sintorn E, Lönnerberg O. Ahlin G, et al. Katilolehti. 1977 Jun;82(6):242-5. Katilolehti. 1977. PMID: 586361 Swedish. No abstract available.

3

Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.

Ahlin G, Chen L, Lazorova L, Chen Y, Ianculescu AG, Davis RL, Giacomini KM, Artursson P. Ahlin G, et al. Pharmacogenomics J. 2011 Dec;11(6):400-11. doi: 10.1038/tpj.2010.54. Epub 2010 Jun 22. Pharmacogenomics J. 2011. PMID: 20567254

4

In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.

Karlgren M, Ahlin G, Bergström CA, Svensson R, Palm J, Artursson P. Karlgren M, et al. Among authors: ahlin g. Pharm Res. 2012 Feb;29(2):411-26. doi: 10.1007/s11095-011-0564-9. Epub 2011 Aug 23. Pharm Res. 2012. PMID: 21861202 Free PMC article.

5

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P. Ahlin G, et al. J Med Chem. 2008 Oct 9;51(19):5932-42. doi: 10.1021/jm8003152. Epub 2008 Sep 13. J Med Chem. 2008. PMID: 18788725

6

A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2).

Matsson P, Englund G, Ahlin G, Bergström CA, Norinder U, Artursson P. Matsson P, et al. Among authors: ahlin g. J Pharmacol Exp Ther. 2007 Oct;323(1):19-30. doi: 10.1124/jpet.107.124768. Epub 2007 Jul 6. J Pharmacol Exp Ther. 2007. PMID: 17616561

7

Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines.

Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. Hilgendorf C, et al. Among authors: ahlin g. Drug Metab Dispos. 2007 Aug;35(8):1333-40. doi: 10.1124/dmd.107.014902. Epub 2007 May 11. Drug Metab Dispos. 2007. PMID: 17496207

8

Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs.

Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlén M, Artursson P. Ahlin G, et al. Drug Metab Dispos. 2009 Dec;37(12):2275-83. doi: 10.1124/dmd.109.028654. Epub 2009 Sep 9. Drug Metab Dispos. 2009. PMID: 19741037

9

Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.

Fridén M, Bergström F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U. Fridén M, et al. Among authors: ahlin g. Drug Metab Dispos. 2011 Mar;39(3):353-62. doi: 10.1124/dmd.110.035998. Epub 2010 Dec 13. Drug Metab Dispos. 2011. PMID: 21149540

10

[Confusing guidelines for psychotherapy].

Ahlin G, Häggmark A. Ahlin G, et al. Lakartidningen. 1998 Jun 3;95(23):2674-5. Lakartidningen. 1998. PMID: 9656618 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results